| A | B | C | |
|---|---|---|---|
| 1 | Drugs | ||
| 2 | Brand | fka LY2062430 | |
| 3 | Generic | solanezumab | |
| 4 | Company | Eli Lilly | |
| 5 | MOA | pm for mid-domain epitope of soluble monomeric AB. Does not bind preformed deposited AB or AB plaques. | |
| 6 | KLVFFAEDVGS (AA 16-26), nucleation site for oligomerization of AB40/AB42 | ||
| 7 | Potential cross-reactivity in human plasma |